在不同的瘤类型中,CD8 T细胞识别的新抗原的特性
S L C Ketelaars1, M M van Buuren1, A Gangaev1
1Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Immuno-oncology technology
|August 4, 2025
概括
对新抗原免疫性进行计算预测对于癌症免疫疗法至关重要. 这项研究表明,解解联体得分和HLA结合亲和力是各种瘤类型的关键预测因素,指导未来的免疫疗法开发.
科学领域:
- 免疫学 免疫学 免疫学
- 计算生物学 计算生物学
- 在瘤学瘤学.
背景情况:
- 基于新抗原的免疫疗法利用计算工具来预测的免疫性.
- 目前的预测模型受到黑色素瘤和肺癌等高度突变的瘤稀缺数据的限制.
- 其他瘤类型的关键性质的预测价值仍然不确定.
研究的目的:
- 研究新抗原特性在不同癌症类型中的免疫性方面的预测价值.
- 评估预测的新抗原特性与CD8 T细胞反应之间的相关性.
- 为了确定超越黑色素瘤和肺癌的新抗原免疫性的主要预测因素.
主要方法:
- 来自CD8T细胞识别幕的免疫性新抗原的回顾性分析.
- 利用了来自12名黑色素瘤患者的瘤透淋巴细胞 (TIL) 和来自14名患有间皮瘤,三阴性乳腺癌或泌尿器癌的患者的PBMC.
- 评估CD8T细胞识别使用组合性-HLA (pHLA) 基于多分子技术.
主要成果:
- 检测到的CD8T细胞反应与预测的新抗原的0.4% (34/8103) 相比.
- 解联体 (EL) 评分是免疫性最强的预测指标,其次是预测的HLA结合亲和力,在PBMC和TIL中.
- 在TIL中,新抗原特异性CD8T细胞频率与EL得分和HLA结合亲和力有很强的相关性.
结论:
- 埃尔评分和HLA结合亲和力是不同瘤类型中新抗原免疫性有价值的预测因素.
- 在ex vivo扩展的TIL培养物中展示了新抗原特异性CD8T细胞反应的免疫主导层次.
- 突出了在更广泛的癌症免疫治疗应用中改善新抗原预测的潜力.
更多相关视频
09:53Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
Published on: February 6, 2017
11.5K
10:13Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
9.1K
相关概念视频
T Cell Activation and Clonal Selection
4.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
4.7K
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Cytotoxic T Cells-mediated Immune Response
2.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.0K
